Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
The U.S. Food and Drug Administration (FDA) has announced the approval of a new containment device for use with certain power morcellators.
The PneumoLiner system is designed to effectively isolate and contain uterine tissue not believed to be cancerous that is created by breaking up fibroids during morcellation.
Because the device has not yet been proven to reduce the spread of potentially cancerous tissue, the FDA is not recommending laparoscopic uterine surgery using power morcellation for the majority of women who require this type of surgery.
The approval comes amid lawsuits alleging that women were put at risk of serious cancer by the use of power morcellators during laparoscopic uterine surgery.
Power Morcellator lawsuits continue to be filed on behalf of women who believe the spinning blades of the morcellator spread deadly cancers to their body and worsened their outcome.
Power morcellators are used to cut and shred uterine tissue so it can be removed from the body through a small opening during minimally invasive surgical procedures.
But as the morcellator chops up tissue, it disperses this tissue throughout the abdomen, where the cells attach to the intestines or intestinal wall, or spread to other areas of the body.
If the tissue contains cancer cells, morcellation can cause immediate upstaging of the disease, taking it from a potentially treatable Stage 1 cancer to Stage 4 terminal cancer.
The PneumoLiner would contain this tissue and not allow it to be spread throughout the abdomen.
Minimally Invasive Hysterectomies Popular in the U.S.
An estimated 600,000 hysterectomies are performed annually in the U.S., and the FDA first approved power morcellators in 1991, paving the way for doctors to do minimally invasive hysterectomies.
The FDA revised its assessment of the cancer risk associated with morcellation in 2014, estimating that one in every 350 women who undergoes a hysterectomy for fibroids has an undetectable cancer that could potentially be spread by morcellation.
It is estimated that everyday that 2-5 women are exposed to cancerous tissues spread throughout their body as a result of power morcellation – a totally avoidable practice.
Women need to understand these risks before choosing the “minimally invasive” surgery.
PneumoLiner may become an answer in the future, but today, the best answer is to make women aware of the dangers and ban the use of power morcellation.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
On Thursday, the FDA notified the public of a recall initiated by Abbott Diabetes Care Inc. of three lots of its FreeStyle Libre 3 sensor, which is a component of the company’s FreeStyle Libre 3 Continuous Glucose Monitoring System. The company says that the implicated
According to the FDA, Carson City-based company Sierra Stain LLC recalled three shades of water-based tattoo inks from its Bloodline brand due to the presence of high levels of microorganisms. Sierra Stain announced the recall on August 23, 2024. The recall pertains to three shades
The FDA recently notified the public of a recall issued by Inari Medical regarding updating instructions for use of its ClotTriever XL Catheter 30mm device after reports of injury and death. The recall does not involve the removal or discontinuation of the product itself, but